The Japanese firm announced last year that it would acquire U.S. Steel Corp. in a $14.9 billion deal — a move that was sharply criticized by lawmakers on both sides of the aisle.
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that the Data Safety Monitoring Board (DSMB) ...